DELFINI LISA (Chief Financial Officer) sold 2.1% of their position (785.00 shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/12/2023ACC: 0001209191-23-052687
Officer· Chief Financial Officer
Since Aug 2021
-785.00
Net shares
Net seller
$1.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.29K acquired · 3.08K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.29K
Price / share
$0.51
Trade value
$1.17K
% of position
6.7%
10/11/2023
34.39K→36.69K
Common Stock
Direct
Shares
−785.00
Price / share
$2.02
Trade value
$1.59K
% of position
2.1%
10/11/2023
36.69K→35.90K
Total
Net shares
+1.51K
Net value
-$414.49
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/11/2023 | M · Option Exercise | +2.29K | $0.51 | $1.17K | 6.7% | 34.39K | 36.69K |
| Common Stock Direct | 10/11/2023 | S · Sale | −785.00 | $2.02 | $1.59K | 2.1% | 36.69K | 35.90K |
| Total | +1.51K | -$414.49 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
2.29K shares
Shares
−2.29K
Strike price
0.511
Held after
64.17K
Exercisable
—
10/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2.29K shares | 10/11/2023 | M · Option Exercise | −2.29K | 0.511 | — | 64.17K |